CDSCO panel recommends market authorization for Covovax jab as heterologous booster dose MD Bureau13 Jan 2023 3:21 PM ISTNew Delhi: An expert panel of the central drugs regulatory authority is likely to take a decision on Wednesday on granting market authorisation to...
Conduct trial with additional safety arm of 1800 subjects: CDSCO Panel Tells Bharath Biotech on Cholera Vaccine Dr. Divya Colin10 Jan 2023 6:00 PM ISTNew Delhi: Regarding the already approved Phase III clinical trial protocol of Cholera Vaccine (Inactivated Vibrio cholarae, MS 1568, Oral), the...
Bharat Biotech partner Ocugen announces positive top-line data for COVID vaccine Covaxin Ruchika Sharma10 Jan 2023 12:40 PM ISTCOVAXINâ„¢ is a highly purified and inactivated vaccine that is manufactured using a vero cell manufacturing platform.
COVID-19 vaccination safe in patients with history of multisystem inflammatory syndrome in children: JAMA Dr. Kamal Kant Kohli10 Jan 2023 9:30 AM ISTUSA: A recent study in JAMA Network Open showed that history of multisystem inflammatory syndrome in children (MIS-C) is not associated increased risk...
Pfizer 20-Valent Pneumococcal Conjugate Vaccine for infants, children accepted by USFDA for Priority Review Ruchika Sharma8 Jan 2023 4:15 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review a supplemental Biologics...
Three-dose whole sporozoite vaccine efficacious, safe against endemic malaria Dr. Kamal Kant Kohli7 Jan 2023 11:15 AM ISTWest Africa: A recent study published in Science Translational Medicine has shown the safety and efficacy of a three-dose regimen of Plasmodium...
Researchers develop bifunctional cancer cell-based vaccine to simultaneously kill and prevent brain cancer Dr. Kamal Kant Kohli7 Jan 2023 9:30 AM ISTUsing gene engineering, the researchers are repurposing cancer cells to develop a therapeutic that kills tumor cells and stimulates the immune system...
COVID-19 vaccines, prior infection reduce transmission of Omicron Dr. Kamal Kant Kohli6 Jan 2023 8:00 PM ISTStudy in California Prisons Found Recent Vaccination and Boosters Reduce Infectiousness, but Infection Risk Remains High.Vaccination and boosting,...
Lumpy skin disease vaccine: Govt collaborates with Institute of Veterinary Biological Products for commercial production of Lumpi-ProVac Ruchika Sharma2 Jan 2023 11:35 AM ISTLumpi-ProVac is used for the prophylactic immunization of animals against lumpy skin disease which gives protection for about one year.
Ebola vaccine regimens safe, immunogenic in adults and children Dr. Kamal Kant Kohli2 Jan 2023 10:00 AM ISTTwo randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens...
Novavax begins Phase 2 trial for COVID-Influenza Combo, influenza stand-alone vaccines Ruchika Sharma1 Jan 2023 11:30 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
3 months of waiting after infection to get booster COVID19 shot can maximize increase in antibody levels Dr.Niharika Harsha B31 Dec 2022 11:30 AM ISTA new study found that a waiting period of 3 months for the third dose of mRNA vaccine elicits robust humoral immune response among those who...
